32 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
was primarily due to a $2,287,000 increase in expenses for clinical studies and pre-clinical studies, partially offset by a $302,000 decrease in share … and consumption of materials, which was partially offset by a $247,000 decrease in lease payments and overhead expenses related to our manufacturing plant space
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
for clinical studies and pre-clinical studies, offset by a decrease in lease payments and overhead expenses related to our plant space.
General … in insurance expenses, a decrease in professional fees and a decrease in payroll expenses, offset by an increase in rent and maintenance expenses.
Net
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
was primarily due to a $2,054,000 increase in expenses for clinical studies and pre-clinical studies, partially offset by a $189,000 decrease in share based … of materials, offset by a $219,000 decrease in lease payments and overhead expenses related to our manufacturing plant space.
General
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
. The increase of 11% was primarily due to an increase in expenses for clinical studies and pre-clinical studies, offset by a decrease in lease payments … , net, which was partially offset by an increase in the costs of clinical and pre-clinical studies and material consumption.
As of March 31, 2023
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
for clinical studies and pre-clinical studies, offset by a $160,000 decrease in lease payments and overhead expenses related to our plant space. Our plant … regulatory expenses and $119,000 decrease in professional fees, partially offset by an of $186,000 increase in lease and overhead expenses in 2023 on our
6-K
EX-99.2
qf4finf2sicw4r
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
snfd g1v33qkjxbnvug
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
f0gz9fcw
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
di9rlxltj8
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
ler6oc5mf5nzmeo1 l78
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.2
z6lxz9 culw
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.2
l7ifgq
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.2
cuq2k0bg
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K/A
EX-99.2
3ig2ca hviznbtrx
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.2
xmrccwrgey9us5xz
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.2
0md115jk
18 May 20
Condensed Consolidated Financial Statements
4:30pm